← Back
$SNDX All transactions

Syndax Pharmaceuticals Inc

▼ SELL 10b5-1 Plan

$ Value

$273K

Shares

19,200

Price

$14

Filed

Aug 18

Insider

Name

Podlesak Dennis

Title

CIK

0001314595

Roles

Director

Transaction Details

Transaction Date

2025-08-14

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

191,763

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person solely covering equity grants with expiration dates prior to August 21, 2025. Following the sales reported in this Form 4, the Reporting Person has a total of 135,000 options to purchase shares of common stock that are vested and immediately exercisable and no unvested options to purchase shares of common stock. | The sale prices ranged from $13.30 to $14.80. | The sale prices ranged from $14.88 to $15.91. | The sale prices ranged from $15.61 to $16.00. | This option is fully vested.

Filing Info

Accession No.

0000950170-25-109815

Form Type

4

Issuer CIK

0001395937

Podlesak Dennis's History

Date Ticker Type Value
2026-02-04 SNDX A $0
2025-08-18 SNDX M $138K
2025-08-18 SNDX $304K
2025-08-18 SNDX M $0
2025-08-15 SNDX M $138K
2025-08-15 SNDX $298K
2025-08-15 SNDX M $0
2025-08-15 SNDX M $0
2025-08-14 SNDX M $138K
2025-08-14 SNDX $273K

Other Insiders at SNDX (90d)

Insider Bought Sold Last
Podlesak Dennis 2026-02-04
Katkin Keith 2026-02-04
Legault Pierre 2026-02-04
Goldan Keith A.
Chief Financial Officer
$115K 2026-02-09
Metzger Michael A
Chief Executive Officer
$514K 2026-02-09
Huber Martin H. Jr. 2026-02-04
Jarrett Jennifer 2026-02-04
Rizo Aleksandra 2026-02-04
Botwood Nicholas A.J.
Head of R&D, CMO
2026-02-04